Weiqun Peng

14PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyGenome structure and regulationEpigenetics (incl. genome methylation and epigenomics)Process control and simulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 06, 2026
Exhausted CD8+ T cell fate is programmed by dynamic CTCF-mediated enhancer activation and invariant CTCF-imposed barriers.

|Jul 06, 2026
Mapping self-associating chromatin hubs identifies Id proteins as key determinants of exhausted CD8+ T cell fate.

|May 25, 2026
ISWI remodeler facilitates cBAF genomic binding to drive cell fate transition.

|Feb 09, 2026
Chromatin modifiers KMT2D, BAF, and p300 are required for de novo binding of transcription factors on enhancers.

Hieu T Van, Young-Kwon Park, Chengyu Liu

|Nov 26, 2025
PRMT1-SFPQ regulates intron retention to control matrix gene expression during craniofacial development.

Julia Raulino Lima, Nicha Ungvijanpunya, Qing Chen

|Feb 12, 2024
Publisher Correction: The transcriptional cofactor Tle3 reciprocally controls effector and central memory CD8+T cell fates.

Xin Zhao, Wei Hu, Sung Rye Park

Pageof 3

Frequent Collaborators

10 joint publications

Hai-Hui Xue

5 joint publications

Shengen Shawn Hu

5 joint publications

Chongzhi Zang

3 joint publications

Qiang Shan